BioPharma Credit launches $300m London IPO

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Equity
Equity IPOs

BioPharma Credit launches $300m London IPO

Aidan Gregory
March 01, 2017 06:00 pm
lse_logo_PA_230x150
File photo dated 25/08/15 of a sign outside the London Stock Exchange Group in the City of London. The London Stock Exchange has said its £21 billion merger with Germany's Deutsche Borse is likely to be blocked by the European Commission. | Philip Toscano/PA Wire/PA Images

BioPharma Credit, the closed end investment company focused on life sciences, has announced the largest UK IPO of the year so far.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

JP MorganEquity IPOsEquityUKEuropeEMEAGoldman Sachs
AG
Aidan Gregory
Gift this article